Statistics
Publications
129
Citations
14.1K
H-Index
57
Active since
2005
Annick Desjardins is an author at Duke Medical Center specializing in oncology, medicine, and brain tumors.
Publications per year
2005–2025
129
129
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Journal of Clinical Oncology · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Clinical Cancer Research · 2007 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E. Herndon et al. · New England Journal of Medicine · 2018 · 802 citations · Full text
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn et al. · Nature · 2015 · 524 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 129